Yancong Zhang
Yancong Zhang
Eleni Kotsiliti
Eleni Kotsiliti
A people-first, systems-oriented approach to liver disease in HIV infection [0.03%]
以患者为中心的艾滋病肝病综合防治系统的研究与探索
Trenton M White,Giada Sebastiani,Giovanni Guaraldi et al.
Trenton M White et al.
Identifying MASLD patient eligibility for pharmacological therapy: the need to integrate evidence into clinical practice [0.03%]
识别MASLD患者药物治疗的适应症：将证据融入临床实践的必要性
Javier Ampuero,Manuel Romero-Gomez
Javier Ampuero
Sequencing what we eat [0.03%]
我们所吃食物的排序
Lawrence A David,Brenda M Davy
Lawrence A David
Katrina Ray
Katrina Ray
Precision nutrition for the prevention and management of inflammatory bowel disease [0.03%]
精准营养在炎症性肠病预防和管理中的作用
Jie Chen,Lintao Dan,Judith Wellens et al.
Jie Chen et al.
The rising disease burden of inflammatory bowel disease (IBD) parallels the changing dietary landscape accompanying industrialization, underscoring the growing relevance of nutritional science in disease prevention and management. Precision...
Understanding development and cellular plasticity in the pancreas in health and disease [0.03%]
健康与疾病状态下胰腺发育和细胞可塑性的研究进展
Alejo Torres-Cano,Francesca M Spagnoli
Alejo Torres-Cano
Pancreatic development is a dynamic process shaped by coordinated interactions between surrounding non-pancreatic tissues and intrinsic transcription factors, integrated through gene regulatory networks. Advances in single-cell genomics and...
Cirrhosis, portal hypertension and hepatocellular carcinoma: a stage-based approach [0.03%]
肝硬化、门静脉高压和肝细胞癌的分期治疗模式
Manon Allaire,Tamar Taddei,Dominique Thabut et al.
Manon Allaire et al.
Cirrhosis and hepatocellular carcinoma (HCC) are interconnected outcomes of chronic liver disease, with portal hypertension playing a key part in cirrhosis decompensation, and influencing HCC prognosis and treatment. Despite their overlap, ...